首页     联盟介绍     组织机构     联盟会员     产品展示     技术推广     进修学习     病友会     学术进展     学术会议     对外合作     联系我们    
联盟动态
 
联合镇痛 无痛中国 ——中国疼痛诊疗康复产学研...
第一届全国骨关节疾病微创治疗技术新进展高级...
2017中国疼痛诊疗康复产学研论坛暨第十一届全国...
第七届全国超声引导可视化疼痛治疗技能演练培...
第十二届全国神经痛微创介入治疗学习班通知
2016中国疼痛诊疗康复产学研论坛暨第十届全国临...
怀来基地挂牌仪式在同济医院隆重举行
唐山工人医院与北京宣武医院结成战略联盟
首都医科大学宣武医院疼痛诊疗中心卫人中医医...
京津冀协同推动疼痛诊疗技术下基层
 
联盟动态
Efficacy of coblation technology in treating cervical discog
更新时间:2015-07-09 14:21  作者:小平

【标题】:Efficacy of coblation technology in treating cervical discogenic upper back pain

【作者】:He, L.; Tang, Y.; Li, X. (...)

【来源】:Medicine (Baltimore), 2015, 94(20), e858

【摘要】:Upper back pain originating from the cervical disk itself is defined as cervical  discogenic upper back pain. Coblation procedures can provide therapeutic effects  for neck and radicular pain related to contained cervical disk herniation. However, no studies have reported the performance of coblation procedures, particularly for treating cervical discogenic upper back pain. The purpose of this study was to evaluate the efficacy of coblation procedures in treating cervical discogenic upper back pain.In a prospective, clinical, observational study, 28 consecutive patients with discogenic upper back pain underwent coblation procedures on the cervical disk with a percutaneous anterior approach.  Pain visual analogue scale (VAS) scores, patient responses stating significant (>/=50%) pain relief, significant (>/=50%) reduction in pain medicine intake and  Modified MacNab criteria were adopted to evaluate the pain intensity, degree of pain relief, and functional status after 12 months of follow-up.The preoperative  pain VAS score was 6.5 +/- 1.1 (95% confidence interval [CI] 6.085-6.915), and the pain VAS score significantly decreased to 2.4 +/- 1.3 (95% CI 1.929-2.928), 2.5 +/- 1.5 (95% CI 1.963-3.109), 2.7 +/- 1.4 (95% CI 2.157-3.271), 3.1 +/- 1.6 (95% CI 2.457-3.686), and 3.1 +/- 1.6 (95% CI 2.471-3.743) at 1 week and 1, 3, 6, and 12 months postoperatively, respectively (P < 0.05). Twenty-two (78.6%), 21 (75.0%), 20 (71.4%), 19 (67.9%), and 18 (64.3%) of the patients expressed significant pain relief at 1 week and 1, 3, 6, and 12 months postoperatively, respectively. 24 (85.7%), 23 (82.1%), 23 (82.1%), and 22 (78.6%) reported significant reduction in pain medication intake at 1, 3, 6, and 12 months postoperatively, respectively. According to the Modified MacNab criteria, the numbers of patients with "excellent" or "good" ratings were 22 (78.6%), 21 (75.0%), 20 (71.4%), and 18 (64.3%) at 1, 3, 6, and 12 months postoperatively, respectively. No serious complications were observed.The findings of this study showed that coblation is an effective, safe, minimally invasive, and less uncomfortable procedure for the treatment of discogenic upper back pain.

 

联系地址:北京市西城区长椿街45号首都医科大学宣武医院疼痛科 邮政编码:100053 
电话:010-83153105  邮箱:xwpain@263.net
© 2015  北京高新疼痛诊疗产业技术创新战略联盟  版权所有   备案号: 京ICP备15038256号
您是第339460来访者


疼痛联盟 疼痛联盟